Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

cermaVEIN

www.cermavein.com

Latest From cermaVEIN

Start-Up News

Noteworthy news from medtech start-ups. This month's we feature Aleva Neurotherapeutics, whose electrodes enable precise and target-specific deep brain stimulation, and cermaVEIN, which is developing steam ablation technology for treating varicose veins.

Start-Up Previews (10/2011)

This Month's Profile Group: The New Ophthalmic Drug Players, features profiles of Imagen Biotech, KalVista Pharmaceuticals, ONL Therapeutics and Xcovery Vision. Plus these Start-Ups Across Health Care: Acetylon Pharmaceuticals, Aleva Neurotherapeutics, cermaVEIN and Flex Biomedical.

cermaVEIN

Treatment for often painful and unsightly varicose veins involves shutting down defective veins and rerouting the blood to nearby healthy veins. For the most prevalent type of varicose vein, the greater saphenous vein. the standard of care is endovascular thermal ablation, whereby the vein is heated from the inside, boiling the blood and sealing the vein closed. But nstead of using RF or laser energy to heat the vein by inserting a catheter with a guidewire, cermaVEIN has found success with simple steam ablation, which avoids boiling the blood and does not require a guidewire.
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • cermaVEIN
  • Senior Management
  • Sophie Humbert, PhD, CEO
  • Contact Info
  • cermaVEIN
    Phone: 450 82 01 76
    Parc d’Affaires International, Bâtiment
    Actipro
    Archamps, 74160
    France
UsernamePublicRestriction

Register